Association of pulmonary tuberculosis and diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000-2012

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Delgado Sánchez, Guadalupe ^a   García García, Lourdes ^a   Castellanos Joya, Martín ^b   Cruz Hervert, Pablo ^a   Ferreyra Reyes, Leticia ^a   Ferreira Guerrero, Elizabeth ^a   Hernández, Andrés ^c   Ortega Baeza, Victor Manuel ^a   Montero Campos, Rogelio ^a   Sulca, José Antonio ^b   Martínez Olivares, Ma De Lourdes ^b   Mongua Rodríguez, Norma ^a   Baez Saldaña, Renata ^a   González Roldán, Jesús Felipe ^b   López Gatell, Hugo ^a   Ponce de León, Alfredo ^d   Sifuentes Osornio, José ^d   Jiménez Corona, María Eugenia ^e  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b Centro Nacional de Programas Preventivos y Control de Enfermedades   (Mexico)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e Dirección General Adjunta de Epidemiología   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; AGE; ANTIBIOTIC RESISTANCE; ARTICLE; DEATH; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE REGISTRY; DRUG TREATMENT FAILURE; FEMALE; HEALTH CARE ACCESS; HISTOPATHOLOGY; HUMAN; INCIDENCE; INFECTION RATE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEXICO; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; SOCIAL SECURITY; SPUTUM EXAMINATION; THORAX RADIOGRAPHY; TIME SERIES ANALYSIS; TREND STUDY; AGED; COMPLICATION; DIABETES MELLITUS, TYPE 2; HEALTH SURVEY; HISTORY; ODDS RATIO; REGISTER; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; MALE; MEXICO; MIDDLE AGED; ODDS RATIO; PUBLIC HEALTH SURVEILLANCE; REGISTRIES; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84949836738     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129312     Document Type: Article

References (45)

1. World Health Organization. Global tuberculosis control: WHO Report 2013. Available: http://apps.who. int/iris/bitstream/10665/91355/1/9789241564656-eng.pdf. Accessed 2013 Dec.
2. International Diabetes Federation. IDF Diabetes Atlas. Sixth edition, 2013. Available: http://www.idf. org/diabetesatlas. Accessed 2014 Jul.
3. Hernandez-Avila M, Gutiérrez J. Diabetes mellitus in Mexico. Status of the epidemic [Diabetes mellitus en México. El estado de la Epidemia]. Salud Publica Mex. 2013; 55(Suppl 2):S129-S36. PMID: 24626688
4. International Diabetes Federation. IDF Diabetes Atlas. Fifth edition, 2011. Available: http://www.idf.org/diabetesatlas. Accessed 2012 Jul.
5. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Medicine. 2008; 5(7):e152. Epub 2008/07/18. doi: 10.1371/journal. pmed.0050152 PMID: 18630984; PubMed Central PMCID: PMC2459204.
6. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Medicine. 2011; 9:81. Epub 2011/07/05. doi: 10.1186/1741-7015-9-81 PMID: 21722362; PubMed Central PMCID: PMC3155828.
7. Jimenez-Corona ME, Cruz-Hervert LP, Garcia-Garcia L, Ferreyra-Reyes L, Delgado-Sanchez G, Bobadilla-Del-Valle M, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2013; 68(3):214-20. Epub 2012/12/20. doi: 10.1136/thoraxjnl-2012-201756 PMID: 23250998; PubMed Central PMCID: PMC3585483.
8. Secretaria de Salud. Norma Oficial Mexicana NOM-017-SSA2-1994, Para la vigilancia epidemiológica. Diario Oficial de la Federación, Mexico, 1994.
9. nd ed. Mexico City: Secretaria de Salud; 1994.
10. Secretaría de Salud. Modificación a la Norma Oficial Mexicana. NOM-006-SSA2-1993. Para la prevención y control de la tuberculosis en la atención primaria a la salud. Diario Oficial de la Federación, 2000.
11. Secretaria de Salud. Norma Oficial Mexicana NOM-015-SSA2-1994, Para la prevención, tratamiento y control de la diabetes. Diario Oficial de la Federación, 2000.
12. th ed. Washington D.C.: ASM Press; 2011. p. 472-502.
13. Instituto Nacional de Salud Publica. Encuesta Nacional de Salud 2000. Vivienda, población y utilización de servicios de salud. Available: www.insp.mx/ensa/ensa-tomo1.pdf. Accessed 2015 Apr.
14. Centers for Disease Control and Prevention. Self-reported prevalence of diabetes among Hispanics-United States, 1994-1997. MMWR Morbidity and Mortality Weekly Report. 1999; 48(1):8-12. Epub 1999/02/05. PMID: 9933122.
15. Gutiérrez J, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública (MX), 2012.
16. Barquera S, Tovar-Guzman V, Campos-Nonato I, Gonzalez-Villalpando C, Rivera-Dommarco J. Geography of diabetes mellitus mortality in Mexico: an epidemiologic transition analysis. Archives of Medical Research. 2003; 34(5):407-14. Epub 2003/11/07. doi: 10.1016/S0188-4409(03)00075-4 PMID: 14602508.
17. Secretaría de Salud. Modificación a la Norma Oficial Mexicana. NOM-006-SSA2-1993. Para la prevención y control de la tuberculosis en la atención primaria a la salud. Diario Oficial de la Federación, 2005.
18. Instituto Nacional de Estadística y Geografía. Censos y conteos de población y vivienda. Available: http://www.inegi.org.mx/est/contenidos/Proyectos/ccpv/. Accessed2013 Mar.
19. Villalpando S, Shamah-Levy T, Rojas R, Aguilar-Salinas CA. Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993-2006. Salud Publica Mex. 2010; 52 Suppl 1:S72-9. PMID: 20585732.
20. Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino- Gomez JL, Olaiz-Fernandez G, et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care. 2004; 27(7):1584-90. PMID: 15220232.
21. Restrepo BI, Fisher-Hoch SP, Crespo JG, Whitney E, Perez A, Smith B, et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiology and Infection. 2007; 135(3):483-91. Epub 2006/07/26. doi: 10.1017/S0950268806006935 PMID: 16863600; PubMed Central PMCID: PMC2870584.
22. Alisjahbana B, van Crevel R, Sahiratmadja E, den Heijer M, Maya A, Istriana E, et al. Diabetes mellitus is strongly associated with tuberculosis in Indonesia. The International Journal of Tuberculosis and Lung Disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2006; 10(6):696-700. Epub 2006/06/17. PMID: 16776459.
23. Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. The International Journal of Tuberculosis and Lung Disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2006; 10(1):74-9. Epub 2006/02/10. PMID: 16466041.
24. Dye C, Bourdin Trunz B, Lonnroth K, Roglic G, Williams BG. Nutrition, diabetes and tuberculosis in the epidemiological transition. PloS One. 2011; 6(6):e21161. doi: 10.1371/journal.pone.0021161 PMID:21712992; PubMed Central PMCID: PMC3119681.
25. Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health. 2007; 7:234. Epub 2007/09/08. doi: 10.1186/1471-2458-7-234 PMID: 17822539; PubMed Central PMCID: PMC2001194.
26. Jung RS, Bennion JR, Sorvillo F, Bellomy A. Trends in tuberculosis mortality in the United States, 1990-2006: a population-based case-control study. Public Health Reports. 2010; 125(3):389-97. Epub 2010/05/04. PMID: 20433033; PubMed Central PMCID: PMC2848263.
27. Murray M, Oxlade O, Lin HH. Modeling social, environmental and biological determinants of tuberculosis. The International Journal of Tuberculosis and Lung Disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2011; 15 Suppl 2:S64-70. doi: 10.5588/ijtld.10.0535 PMID: 21740661.
28. Restrepo BI, Schlesinger LS. Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis. 2013; 93 Suppl:S10-4. doi: 10.1016/S1472-9792(13)70004-0 PMID: 24388642.
29. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Social Science & Medicine. 2009; 68(12):2240-6. doi: 10.1016/j.socscimed.2009.03.041 PMID: 19394122.
30. Gomez DI, Twahirwa M, Schlesinger LS, Restrepo BI. Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control. Tuberculosis. 2013; 93 (2):192-7. doi: 10.1016/j.tube.2012.10.003 PMID: 23131496; PubMed Central PMCID: PMC3580120.
31. Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, Mora F, et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America. 2008; 47(5):634-41. doi: 10.1086/590565 PMID: 18652554; PubMed Central PMCID: PMC2900313.
32. Gonzalez Y, Herrera MT, Soldevila G, Garcia-Garcia L, Fabian G, Perez-Armendariz EM, et al. High glucose concentrations induce TNF-alpha production through the down-regulation of CD33 in primary human monocytes. BMC Immunology. 2012; 13:19. doi: 10.1186/1471-2172-13-19 PMID: 22500980;PubMed Central PMCID: PMC3353220.
33. Wang CH, Yu CT, Lin HC, Liu CY, Kuo HP. Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis. 1999; 79(4):235-42. PMID: 10692992.
34. Al-Attiyah RJ, Mustafa AS. Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guerin (BCG)-vaccinated healthy subjects. Clinical and Experimental Immunology. 2009; 158(1):64-73. Epub 2009/09/10. doi: 10.1111/j.1365-2249.2009.04000.x PMID:19737232; PubMed Central PMCID: PMC2759060.
35. Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Nutman TB, Babu S. Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. The Journal of Infectious Diseases. 2013; 208(5):739-48. Epub 2013/05/30. doi: 10.1093/infdis/jit241 PMID: 23715661; PubMed Central PMCID: PMC3733509.
36. Tsukaguchi K, Okamura H, Matsuzawa K, Tamura M, Miyazaki R, Tamaki S, et al. [Longitudinal assessment of IFN-gamma production in patients with pulmonary tuberculosis complicated with diabetes mellitus]. Kekkaku: [Tuberculosis]. 2002; 77(5):409-13. PMID: 12073618.
37. Vallerskog T, Martens GW, Kornfeld H. Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. Journal of Immunology. 2010; 184(11):6275-82. doi: 10.4049/jimmunol. 1000304 PMID: 20421645; PubMed Central PMCID: PMC2874741.
38. Stevenson CR, Critchley JA, Forouhi NG, Roglic G, Williams BG, Dye C, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illness. 2007; 3(3):228-45. doi: 10.1177/1742395307081502 PMID: 18083679.
39. Dolhofer R, Siess EA, Wieland OH. Nonenzymatic glycation of immunoglobulins leads to an impairment of immunoreactivity. Biological Chemistry Hoppe-Seyler. 1985; 366(4):361-6. PMID: 4026990.
40. Babalik A, Ulus IH, Bakirci N, Kuyucu T, Arpag H, Dagyildizi L, et al. Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus. Antimicrobial Agents and Chemotherapy. 2013; 57(11):5740-2. doi: 10.1128/AAC.01345-13 PMID: 23979746; PubMed Central PMCID: PMC3811326.
41. Hicks R, Padayatchi N, Shah N, Wolf A, Werner L, Sunkari V, et al. Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children. The International Journal of Tuberculosis and Lung Disease. 2014; 18(9):1074-83. doi: 10.5588/ijtld.14.0231 PMID: 25189555
42. Garcia-Garcia ML, Ponce de Leon A, Jimenez-Corona ME, Jimenez-Corona A, Palacios-Martinez M, Balandrano-Campos S, et al. Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico. Arch Intern Med. 2000; 160(5):630-6. PMID: 10724048.
43. Jimenez-Corona ME, Garcia-Garcia L, DeRiemer K, Ferreyra-Reyes L, Bobadilla-del-Valle M, Cano- Arellano B, et al. Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area. Thorax. 2006; 61(4):348-53. PMID: 16449260.
44. Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest. 2001; 120(5):1514-9. Epub 2001/11/20. PMID: 11713128.
45. Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH, et al. Type 2 diabetes and multidrug-resistant tuberculosis. Scandinavian Journal of Infectious Diseases. 2008; 40(11-12):888-93. Epub 2008/08/30. doi: 10.1080/00365540802342372 PMID: 18728934; PubMed Central PMCID: PMC2887603.